Learn more

NII ONKOLOGII IM PROF N N PETR

Overview
  • Total Patents
    34
About

NII ONKOLOGII IM PROF N N PETR has a total of 34 patent applications. Its first patent ever was published in 1977. It filed its patents most often in Russian Federation and USSR (Union of Socialist Soviet Republics). Its main competitors in its focus markets medical technology, macromolecular chemistry and polymers and environmental technology are G OBRAZOVATEL NOE UCHREZHDENIE VYSSHEGO PROFESSIONAL NOGO OBRAZOVANIJA VLADIVOSTOKSKIJ G MED UNI FED, TASHKENT G MED I and TTC KK.

Patent filings in countries

World map showing NII ONKOLOGII IM PROF N N PETRs patent filings in countries

Patent filings per year

Chart showing NII ONKOLOGII IM PROF N N PETRs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kanaev S V 3
#2 Zhukova L A 3
#3 Novikov S N 3
#4 Kochnev V A 2
#5 Filov V A 2
#6 Kalinovskij Valentin P 2
#7 Belokhvostova Aleksandra T 2
#8 Semiglazov V F 2
#9 Okulov Valerij B 2
#10 Novik V I 2

Latest patents

Publication Filing date Title
RU2220416C2 Method for cytological diagnostics and predicting the flow of wilms tumor in children
RU2203683C1 Method for immunotherapy with medullary dendrite cells in patients with solid tumors
RU2200467C1 Method for determining tumor injury space in bone marrow and residual space occupied by hemopoietic bone marrow in lymphogranulomatosis patients
RU2212035C2 Method for determining indications in favor of chemotherapy application to patients suffering from primary lymphogranulomatosis and generalized mammary gland carcinoma
RU2220418C2 Method for complex evaluation of tumor sensitivity to chemotherapy at mammary gland cancer
RU2214260C2 Method for prophylaxis of stomach cancer
RU2219875C2 Prosthesis of lower extremity and a part of trunk
RU2213520C2 Method for forming radiation fields for irradiating paraortic and ilioinguinal lymph nodes using indirect lower lymphoscintigraphy
RU2200598C2 Method for carrying out topometric patient preparation to spleen irradiation using its radionuclide visualization
RU2219243C2 Method for dna recovery isolated from archives pathomorphological tissue samples
RU2187968C2 Method for diagnosing malignant skin tumors
RU2179555C1 5-oxymethyl-5-[3-(2-chlorethyl)-3- nitrozoureido]-2-cyclohexyl- 1
RU2154993C1 Differential method for diagnosing the cases of soft tissues tumors of the thyroid and mammary gland
RU2151396C1 Method for predicting postoperative complications type in patients suffering from large intestine cancer from anteoperative gastrinemia
RU2088245C1 Method of prophylaxis of the enhanced oncological risk
RU2068843C1 2-[3-(2-chloroethyl)-3-nitrosoureido]-1,3-propanediol showing antitumor activity
RU1815273C Recombinant dna plasmid phrasth@-3 sequence encoding for carcinogen hras1 of human thyroid cancer and method for constructing the same
SU1712419A1 Method of genetic dactyloscopy
SU1693046A1 Strain of hybridous cultured mammalian cells, mus musculus l - a producer of monoclonal antibodies to villebrand factor of human blood clotting system
SU1711066A1 Device for separating high-molecular biological substances in preparations